{"id":"https://genegraph.clinicalgenome.org/r/f45ec33a-49fd-4e82-907d-807475ca5c91v2.3","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *CAPN3* and autosomal recessive limb-girdle muscular dystrophy (LGMDR1 included) has been evaluated using the ClinGen Clinical Validity Framework as of May 2022. The *CAPN3*  gene is located on chromosome 15q15.q and encodes multiple transcript variants. The longest transcript (NM_000070.3) is 3.5 kb long with 24 exons encoding an 821-amino acid protein. Additional transcripts, derived from alternative splicing and the use of alternative promoter have also been identified. More than 250 pathogenic variants reported in patients with autosomal recessive LGMD are recorded in ClinVar, more than 150 of them being predicted loss of function variants. Limb girdle muscular dystrophy is characterized by progressive weakness in muscles including but not limited to the proximal muscles and affecting the pelvic and shoulder girdle which can lead to difficulty walking or complete loss of ambulation requiring wheelchair use. It is also accompanied by elevated serum creatine kinase and dystrophic and myopathic features.\nSummary of case level data (12 points): Variants in this gene have been reported in at least 10 probands in 3 publications (PMID: 7720071, 9150160,10330340). Variants in this gene segregated with disease in 24 additional family members. More case-level evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. The mechanism for disease is expected to be biallelic loss of function.\nSummary of Experimental Data (6 points): This gene-disease relationship is supported by expression studies, biochemical function, protein interaction, animal models, and rescue evidence. Calpain 3 (*CAPN3*) is a muscle-specific member of the calpain family Ca2+ dependent cysteine proteases and localizes to sarcomere in skeletal muscle (PMID: 9521867, 9777948,15138196, 10229226). Calpain 3 is activated by autolysis. Calpain 3 interacts with multiple skeletal muscle sarcomere and sarcolemma proteins, and many of which are cleaved by active Calpain 3 (PMID: 15138196, 15827562). While the known Calpain 3 substrate list is likely incomplete, Calpine 3 plays important functions in muscle calmodulin pathway, skeletal mTORC1 signaling, mitochondrial biogenesis, and apoptosis (PMID: 10229226, 25389288, 33308300). A number of mouse models by targeted knockout and gene trapping of *CAPN3*  are reported with phenotype and muscle histological defects similar to human patients with AR-LGMD (PMID: 33308300, 15138196). And rescue in mouse models are also reported (PMID: 16290124, 34514031).\nIn summary, the *CAPN3* -autosomal recessive limb-girdle muscular dystrophy gene-disease relationship is definitive. This is demonstrated in both research and clinical diagnostic settings and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f45ec33a-49fd-4e82-907d-807475ca5c91","GCISnapshot":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:expertPanelChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10151","date":"2024-08-29T16:50:23.611Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10151","date":"2024-08-29T19:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e6a1056-119f-4b7c-9ca5-0e20ad882705_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e6a1056-119f-4b7c-9ca5-0e20ad882705","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"III-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f2b8eb5e-1ae1-4ed6-bd92-a6fef8bcc84c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2243G>A (p.Arg748Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345536"}},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0003797","obo:HP_0003236"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8cb6a185-79c7-40d5-880a-bc9f824cc11a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2b8eb5e-1ae1-4ed6-bd92-a6fef8bcc84c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/8cb6a185-79c7-40d5-880a-bc9f824cc11a","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cb6a185-79c7-40d5-880a-bc9f824cc11a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8cb6a185-79c7-40d5-880a-bc9f824cc11a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Affected autolytic activity (PMID_9642272, PMID_19226146), by expression and protein detection in a biopsy from a patient carrying a compound heterozygous frameshifting mutation.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/63de30f5-c0f2-4c29-ab72-ab624fb27ffc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63de30f5-c0f2-4c29-ab72-ab624fb27ffc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"Amish","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2306G>A (p.Arg769Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127306"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"HP:0003236, HP:0003797, HP:0003701\n","phenotypes":["obo:HP_0003236","obo:HP_0003701","obo:HP_0003797"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0224e68-eb99-4778-936f-8337d7672cfa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d0224e68-eb99-4778-936f-8337d7672cfa","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0224e68-eb99-4778-936f-8337d7672cfa_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d0224e68-eb99-4778-936f-8337d7672cfa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID_9642272, rapid autolytic p94 and functional defect","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ff8f745c-3e3b-4159-80ee-f70c22094f4c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff8f745c-3e3b-4159-80ee-f70c22094f4c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","rdfs:label":"Greece-University of Newcastle","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9747977e-8512-4d74-b481-bacff0e48ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2114A>G (p.Asp705Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392001588"}},{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.550del (p.Thr184ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA220352"}}],"detectionMethod":"Multiple and nonuniform strategies were applied in this study.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"symmetrical and selective atrophy of the pelvic, scapular, and trunk muscles","phenotypes":["obo:HP_0003236","obo:HP_0008946","obo:HP_0009060"],"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8957703a-84a7-40c9-9efd-ea60a2d70d8e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","allele":{"id":"https://genegraph.clinicalgenome.org/r/9747977e-8512-4d74-b481-bacff0e48ffe"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3798ab46-08e9-481c-9bc6-2a268165aa9c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3798ab46-08e9-481c-9bc6-2a268165aa9c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3798ab46-08e9-481c-9bc6-2a268165aa9c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8957703a-84a7-40c9-9efd-ea60a2d70d8e","type":"EvidenceLine","dc:description":"PMIM_21624972, D705G in vitro and in vivo model; dominant-negative, titin binding affected.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8957703a-84a7-40c9-9efd-ea60a2d70d8e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/360aa062-7e2f-4e6b-8c5d-b6cdd3b737e2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/360aa062-7e2f-4e6b-8c5d-b6cdd3b737e2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1d2a26e0-50ce-4c58-a9a0-11a24312635d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2362_2363delinsTCATCT (p.Arg788SerfsTer14)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127307"}},{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.643_663del (p.Ser215_Gly221del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347563"}}],"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Onset at 10-14, loss walking at 28-29 yo. CK at 5000 ","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ee8c1aae-a7ae-4a36-b994-8da53c7093c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d2a26e0-50ce-4c58-a9a0-11a24312635d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/457af2a9-ebd3-463e-8e9d-74754aa350ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/457af2a9-ebd3-463e-8e9d-74754aa350ec","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/457af2a9-ebd3-463e-8e9d-74754aa350ec_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ee8c1aae-a7ae-4a36-b994-8da53c7093c4","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee8c1aae-a7ae-4a36-b994-8da53c7093c4_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/dc8ee58b-8fc1-4221-8cea-2f584df86480_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc8ee58b-8fc1-4221-8cea-2f584df86480","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"703","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7"},"detectionMethod":"Markers based haplotyping, heteroduplex based variant screening, and direct sequencing5","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"high penetrance,","phenotypes":["obo:HP_0003236","obo:HP_0003701","obo:HP_0003797"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5362c000-3e91-4bb0-a9a2-75bab278d974_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5362c000-3e91-4bb0-a9a2-75bab278d974","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5362c000-3e91-4bb0-a9a2-75bab278d974_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5362c000-3e91-4bb0-a9a2-75bab278d974_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID_9642272, rapid autolytic p94 and functional defect","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/8b1129df-f403-4a9c-92cb-418326690949_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b1129df-f403-4a9c-92cb-418326690949","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IV-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Scapular winging","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9618d51d-3f20-4dce-bdf4-f84308142401_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9618d51d-3f20-4dce-bdf4-f84308142401","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9618d51d-3f20-4dce-bdf4-f84308142401_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/19a649b3-c3bb-4dc8-9caa-558a2a3f8834_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19a649b3-c3bb-4dc8-9caa-558a2a3f8834","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"1135","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e24035d-4e29-4de9-acbf-ef08dc597654","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.328C>T (p.Arg110Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341471"}},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0bab9dce-09a3-4347-bbe6-eb0354da1001_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e24035d-4e29-4de9-acbf-ef08dc597654"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0bab9dce-09a3-4347-bbe6-eb0354da1001","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bab9dce-09a3-4347-bbe6-eb0354da1001_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbce258a-c793-4c73-9ad1-cca12a37b4d1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"T11","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/dbce258a-c793-4c73-9ad1-cca12a37b4d1","type":"Family","rdfs:label":"T11","member":{"id":"https://genegraph.clinicalgenome.org/r/615c495b-6788-498c-b194-7dc4494d517a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"V-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/677570d0-1092-49ef-9fb2-d0495154f6d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Calf hypertrophy, onset at 12, still walking at 14.","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0003236","obo:HP_0003797"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/615c495b-6788-498c-b194-7dc4494d517a"}},{"id":"https://genegraph.clinicalgenome.org/r/d175c2f5-d278-43b9-b69f-da93121dec5b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"US9344","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/d175c2f5-d278-43b9-b69f-da93121dec5b","type":"Family","rdfs:label":"US9344","member":{"id":"https://genegraph.clinicalgenome.org/r/360aa062-7e2f-4e6b-8c5d-b6cdd3b737e2"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Onset at 10-14, loss walking at 28-29 yo.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/360aa062-7e2f-4e6b-8c5d-b6cdd3b737e2"}},{"id":"https://genegraph.clinicalgenome.org/r/58ac0604-143d-4ae5-b1b8-f2934d92ab82_proband_segregation","type":"FamilyCosegregation","dc:description":"Did not include LOD - parents not all genotyped and consanguinity. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"S5393","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/58ac0604-143d-4ae5-b1b8-f2934d92ab82","type":"Family","rdfs:label":"S5393","member":{"id":"https://genegraph.clinicalgenome.org/r/81a53158-e2ee-4da4-8d0a-d6c8012e9dc3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IV-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c94006f3-c107-44b8-9e17-cc88ec71a91f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1699G>T (p.Gly567Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233622"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"limb-girdle wasting","phenotypes":["obo:HP_0003236","obo:HP_0003797"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a1f4de3a-101f-4cda-9848-70ff3c3ca586_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/c94006f3-c107-44b8-9e17-cc88ec71a91f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"limb-girdle wasting","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003236","obo:HP_0003797"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/81a53158-e2ee-4da4-8d0a-d6c8012e9dc3"}},{"id":"https://genegraph.clinicalgenome.org/r/9ad069de-070e-420f-b5ce-0a32e7c7298b_proband_segregation","type":"FamilyCosegregation","dc:description":"Did not include LOD - parents not all genotyped and consanguinity. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"T14","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/9ad069de-070e-420f-b5ce-0a32e7c7298b","type":"Family","rdfs:label":"T14","member":{"id":"https://genegraph.clinicalgenome.org/r/8e6a1056-119f-4b7c-9ca5-0e20ad882705"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003797","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8e6a1056-119f-4b7c-9ca5-0e20ad882705"}},{"id":"https://genegraph.clinicalgenome.org/r/8c9fefc2-d579-4bd0-ae63-3a419e92c92e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"A","family":{"id":"https://genegraph.clinicalgenome.org/r/8c9fefc2-d579-4bd0-ae63-3a419e92c92e","type":"Family","rdfs:label":"A","member":{"id":"https://genegraph.clinicalgenome.org/r/63de30f5-c0f2-4c29-ab72-ab624fb27ffc"}},"phenotypeFreeText":"HP:0003236, HP:0003797, HP:0003701\n","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0003701","obo:HP_0003236","obo:HP_0003797"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/63de30f5-c0f2-4c29-ab72-ab624fb27ffc"}},{"id":"https://genegraph.clinicalgenome.org/r/02105e20-f9dd-4256-95e5-5220634c1f6e_proband_segregation","type":"FamilyCosegregation","dc:description":"Did not include LOD - parents not all genotyped and consanguinity. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IT5414","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/02105e20-f9dd-4256-95e5-5220634c1f6e","type":"Family","rdfs:label":"IT5414","member":{"id":"https://genegraph.clinicalgenome.org/r/5e56718f-ac60-4f5c-b101-ba14a00196c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"III-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6cb7430f-6393-4a76-b8b5-d80382b0b044_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Limb girdle wasting, Scapulohumeral distribution at the beginning, extensor digitorum brevis muscle hypertrophy","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003797","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5e56718f-ac60-4f5c-b101-ba14a00196c3"}},{"id":"https://genegraph.clinicalgenome.org/r/60274188-b618-4ee5-b1fb-f272f9a14f26_proband_segregation","type":"FamilyCosegregation","dc:description":"Did not include LOD - consanguinity. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"B501","estimatedLodScore":4.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/60274188-b618-4ee5-b1fb-f272f9a14f26","type":"Family","rdfs:label":"B501","member":{"id":"https://genegraph.clinicalgenome.org/r/dc8ee58b-8fc1-4221-8cea-2f584df86480"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"high penetrance,","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0003701","obo:HP_0003797","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dc8ee58b-8fc1-4221-8cea-2f584df86480"}},{"id":"https://genegraph.clinicalgenome.org/r/fec13c4d-bb84-40da-8ac2-8fa3b6fd6bc3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"T18","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/fec13c4d-bb84-40da-8ac2-8fa3b6fd6bc3","type":"Family","rdfs:label":"T18","member":{"id":"https://genegraph.clinicalgenome.org/r/8b1129df-f403-4a9c-92cb-418326690949"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8b1129df-f403-4a9c-92cb-418326690949"}},{"id":"https://genegraph.clinicalgenome.org/r/7092db12-6f15-4ec0-ba92-e98d3c4b443d_proband_segregation","type":"FamilyCosegregation","dc:description":"Did not include LOD - not all parents genotyped and consanguinity. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"B519","estimatedLodScore":7.17,"family":{"id":"https://genegraph.clinicalgenome.org/r/7092db12-6f15-4ec0-ba92-e98d3c4b443d","type":"Family","rdfs:label":"B519","member":{"id":"https://genegraph.clinicalgenome.org/r/19a649b3-c3bb-4dc8-9caa-558a2a3f8834"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":10,"proband":{"id":"https://genegraph.clinicalgenome.org/r/19a649b3-c3bb-4dc8-9caa-558a2a3f8834"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c2e9517b-5c2f-4dbb-b219-4fcb31bce932_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2e9517b-5c2f-4dbb-b219-4fcb31bce932","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","rdfs:label":"French-Ge´ne´thon (R448H)","allele":{"id":"https://genegraph.clinicalgenome.org/r/9204f29c-d47b-48d2-a04a-fd330adf939a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1343G>A (p.Arg448His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347482"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"symmetrical and selective atrophy of the pelvic, scapular, and trunk muscles","phenotypes":["obo:HP_0008946","obo:HP_0003236","obo:HP_0009060"],"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba9e10ec-643e-4a6a-bc7e-b353d5a75dc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","allele":{"id":"https://genegraph.clinicalgenome.org/r/9204f29c-d47b-48d2-a04a-fd330adf939a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/ba9e10ec-643e-4a6a-bc7e-b353d5a75dc5","type":"EvidenceLine","dc:description":"2nd mutation not reported. ","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba9e10ec-643e-4a6a-bc7e-b353d5a75dc5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ba9e10ec-643e-4a6a-bc7e-b353d5a75dc5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID_21624972; R448H led to more rapid degradation and decreased myofibrillar association (impaired titin association).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/81a53158-e2ee-4da4-8d0a-d6c8012e9dc3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81a53158-e2ee-4da4-8d0a-d6c8012e9dc3"},{"id":"https://genegraph.clinicalgenome.org/r/a1f4de3a-101f-4cda-9848-70ff3c3ca586","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1f4de3a-101f-4cda-9848-70ff3c3ca586_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a1f4de3a-101f-4cda-9848-70ff3c3ca586_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No biopsy done?","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/615c495b-6788-498c-b194-7dc4494d517a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/615c495b-6788-498c-b194-7dc4494d517a"},{"id":"https://genegraph.clinicalgenome.org/r/677570d0-1092-49ef-9fb2-d0495154f6d2","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/677570d0-1092-49ef-9fb2-d0495154f6d2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/5e56718f-ac60-4f5c-b101-ba14a00196c3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e56718f-ac60-4f5c-b101-ba14a00196c3"},{"id":"https://genegraph.clinicalgenome.org/r/6cb7430f-6393-4a76-b8b5-d80382b0b044","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cb7430f-6393-4a76-b8b5-d80382b0b044_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30971d89-91a7-4948-8cd1-14f953cdd78d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/466e130d-ffa4-479b-82ac-011ad939582c","type":"Finding","dc:description":"CAPN3 94 kD and 60 kD fragments were both detected by DYSF antibody pull down from human muscle homogenates, but not by the unrelated antibody.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15827562","rdfs:label":"Co-immunoprecipitation CAPN3 by dysferlin antibody","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a065fcdc-4325-4dd7-aeff-a318416585b2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f359fc6b-d807-4270-b62b-ee137991a819","type":"Finding","dc:description":"CAPN3 staining lost in dystrophin+ myofiber in biopsies from multiple LGMD2A patients in contrast to control. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10229226","rdfs:label":"Immunostaining did not detect CAPN3 in LGMD2A patients","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/adf9182a-0b6e-474a-acf2-12f39d2b0bd8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f157f9e-9b5c-49d5-9a5e-04890338ff15","type":"Finding","dc:description":"Protein analysis showed CAPN3 interacts with TITN and cleaves PEVK and M line fragments. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"TTN/CAPN3 association by solid phase binding assay","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/411ba97b-ec69-4930-b0bb-871fd6fd2e4c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebe8b7f4-2e7c-4d72-a4c1-67bc1340ee33","type":"Finding","dc:description":"In LGMD2A patients samples, full-length CAPN3 band and derived bands were undetectable, reduced, or showed different patterns. Such as Fig.4 lane 2 hom splice mutations, lane 4 compound het LOF/ms).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9777948","rdfs:label":"Abnormal CAPN3 expression in LGMD2A patient samples","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/63e6f9ca-0c4f-448c-b0d2-31b87b79e634","type":"EvidenceLine","dc:description":"Scored default score with multiple reports in this same category.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fe3f375-8384-406b-840d-7d792c5c8c99","type":"Finding","dc:description":"CAPN3 mRNA was detected in skeletal muscle by in situ hybridizations (multiple probes) during development stages and semi-RT-PCR in skeletal muscle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9521867","rdfs:label":"CAPN3 mRNA in skeletal muscle by in situ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/89f20fca-c1c2-4e1d-84dc-350c9ed86c52","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a2f5ebb-7f5d-44cc-a666-fde4c9d7f2a5","type":"Finding","dc:description":"Abnormal sarcomere organization was consistent with the muscular dystrophy phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"Sarcomere protein TTN as a CAPN3 proteolytic substrate ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a8b4668b-cff7-4821-af77-c2e8b2b3ea20","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ffb9741d-d467-47dd-9bc7-775bc5db437f","type":"Finding","dc:description":"CAPN3 protein was detected by multiple antibodies in fresh human muscle and breakdown post homogenization. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9777948","rdfs:label":"CAPN3 protein detection in human skeletal muscle","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f3ccab3-b6ca-428c-8be2-250e0373ef53","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70badf4e-f2fc-4b55-8b3d-baa6543415bb","type":"FunctionalAlteration","dc:description":"Loss of CAPN3 D705G mutant protein expression and decreased wild-type CAPN3 protein in skeletal muscle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21624972","rdfs:label":"CAPN3 D705G transgene"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d20a50f9-dd73-42da-a5c9-12d3234bdd0f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb38e39f-147a-4efe-8f86-d903b20ac55d","type":"FunctionalAlteration","dc:description":"CAPN3 R448H mutant is shown as less stable in transgenic muscle, which could be attributed to cellular protease-mediated degradation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21624972","rdfs:label":"CAPN3 R448H tg"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6535c43-0e00-4230-8078-4eccfe4371fd","type":"EvidenceLine","dc:description":"Elegant experiments showed a connection between CAPN3, IKBA by biochemical function, and furthermore IKBA-associated apoptosis in sk muscle cells, which supported a mechanism of elevated apoptosis observed on LGMD1A patient muscle biopsy.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57ca86de-527d-463e-aee2-2fe03c310931","type":"FunctionalAlteration","dc:description":"Elevation of IKBA staining in LGMD2A muscle and correlation with elevated apoptosis; transient IKBA overexpression induced apoptosis in control muscle cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10229226","rdfs:label":"Elevated apoptosis and IKBA misregulation in LGMD2A"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/86925075-3fea-401c-90b3-6b40b2b045ca_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9018cf2-4ee2-44d1-af05-5c75eec7b1e9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b8647dc-1d40-4b43-a828-cdce6002b7fb","type":"Finding","dc:description":"AAVrh74.tMCK.CAPN3 gene therapy resulted in improvements in both functional outcomes and muscle physiology at two dosing levels in two age groups. Treated skeletal muscle showed remodeling of muscle and muscle fiber size improvements by histology.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34514031","rdfs:label":"AAVrh74.tMCK.CAPN3 rescue in two age groups CAPN3 KO mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fda656b7-103b-4af7-b167-bc85d1ceb9d0","type":"EvidenceLine","dc:description":"A comprehensive assessment on expression level, isoform, and clear improvement based on histology for the major phenotype. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7d2030a-0f0b-4628-9de1-51a09642c826","type":"Finding","dc:description":"Histological analysis of muscle biopsy showed evident improvement on muscle dystrophic defects by AAV medicated CAPN3 expression.  AAV medicated CAPN3 expression had positive effects on muscle mess and force with some variations in muscle and injection site. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16290124","rdfs:label":"AAV1-C512-CAPN3fsr expression in CAPN3 -/- muscle","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/de18e0f5-34e4-451f-ab64-b58a160dd742","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a1043a7-4b16-428a-b41c-d1f31e669c43","type":"Finding","dc:description":"Muscle biopsies of CAPN3 gene knockout mice demonstrated similar pathological changes observed in LGMD patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"CAPN3 mouse knockout by gene trap","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/204e126d-659d-42e7-9689-e9268ecd073a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca724352-684a-4452-9034-34bd6af9c6f5","type":"Finding","dc:description":"High Ck, muscle dystrophic change, loss of sarcolemal integrity, central nuclei, and elevated apoptosis are all features observed in LGMD2A patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11134085","rdfs:label":"Targeted CAPN3 ex2-3","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":8895,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/B77mYg7jUEc","type":"GeneValidityProposition","disease":"obo:MONDO_0015152","gene":"hgnc:1480","modeOfInheritance":"obo:HP_0000007"},"version":"2.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_86925075-3fea-401c-90b3-6b40b2b045ca-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}